Established in 2008, Integral Biosciences Pvt. Ltd (IBS) is a drug discovery service provider or incubator, which offers end-to-end integrated drug discovery services to innovation-focused biotech start-ups and small to mid-sized pharmaceutical companies. IBS is a well renowned Contract Research Organisation (CRO) in India providing preclinical development solution.
It is a well-known fact that the process of drug discovery remarkably demands capital and time and both. In 2020, Indian Biotechnology was valued at around USD 70 billion and expected to reach the level of USD 150 billion by 2025. The overall amount spent in the biotechnology sector worldwide was USD 753.48 billion and expected to reach around USD 2.44 trillion by 2028.
Drug designing is a multidisciplinary act and involves several stages. Integrated drug discovery needs expertise from various fields of biosciences at different stages. One of the most important parts of drug discovery and development is DPMK (Drug Metabolism and Pharmacokinetics) studies.
Drug discovery delivers answers for crucial health questions and CRO needs knowledge and expertise of many fields of biosciences. A well-established drug discovery CRO has to be capable enough to resolve the scientific, medical, operational, financial and timeline challenges associated with drug designing phases.
Integral Biosciences Pvt. Ltd (IBS) leading medical research agency in Noida Extension. We have successfully contracted research partnerships.
